Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases
Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases
Not yet recruiting · NCT07413952 · Registry updated 2026-02-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases | non-small cell lung carcinoma | Not yet recruiting | Phase 2 | 2026-02-17 | NCT07413952 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Guangzhou Medical University | 95 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong | Guangzhou | China | 1 |